ORPHAZYME A/S - ADR (ORPH) Stock News
NASDAQ:ORPH - Nasdaq - ADR
ORPH Latest News, Press Relases and Analysis
Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
Orphazyme A/S (NASDAQ: ORPH) has
Dear ORPH Stock Fans, Mark Your Calendars for March 31
After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling.
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Grab your cup of coffee, investor! We're starting off the day with a dive into the biggest pre-market stock movers for Tuesday!
Why Is Orphazyme (ORPH) Stock Up Today?
The troubled biotech company's share price is up 40% despite plans to delist from the Nasdaq exchange and lay off 50% of its workers.
Why Is OXY Stock Up Today? Does Warren Buffett’s Berkshire Want to Buy Occidental Petroleum?
Occidental Petroleum (OXY) stock is rising higher on Thursday following news that Berkshire Hathaway increased its stake in the company.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!